Jin Medical International Ltd. (ZJYL) Form 6-K — Sep 24, 2026
Jin Medical International closed its VIE acquisition of Huaxia Qiying on September 24, 2026, with total consideration of US$159,415,729 in a mix of shares and non-share assets. At Closing the company issued 71,282,488 Class A shares as share consideration, plus 8,479,560 Class A shares to advisor Veltrion Haskel Holdings Limited, bringing total shares outstanding to 158,194,533 — meaning roughly half the post-deal share count was just created in this transaction. The transfer of Changzhou Zhongjin's 80% stake in Zhongjin Kangma did not close; if not completed by October 31, 2026, the company will issue 622,123 substitute shares.
Key figures
- Deal Value Usd
- 159415729
- Shares Outstanding
- 158194533
- Advisor shares
- 8479560
- Class a outstanding
- 153425476
- Class b outstanding
- 4769057
- Kangma equity stake
- 80%
- Share consideration shares
- 71282488
- Substitute kangma shares if delayed
- 622123
AI analysis
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.